NUSIRT SCIENCES, INC.

Sirtuin Activation for Aging and Overnutrition | NuSirt Sciences

Harpers Ferry, United States · Founded 2025 · $1.1M raised

Employees
1–10
Founded
2025
Business Model
B2B2C
Website
nusirt.com
Total Funding
$1.1M

About

NuSirt Sciences is a privately held biopharmaceutical company developing combination therapeutics that activate the sirtuin pathway to address metabolic diseases including obesity, diabetes, MAFLD/MASH, and hypertension. Its lead drug candidate TRIPLN combines L-leucine, metformin, and sildenafil, and has shown promising results in Phase 2 clinical trials. NuSirt also produces LEUSIX, a dietary supplement supporting cardiometabolic health and weight management.

Summary

NUSIRT SCIENCES, INC. is a Biotech company based in Harpers Ferry, United States, founded in 2025. It has raised $1.1M in total.

Tech & App Stack

3 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies